COVID-19-associated hyperviscosity: a link between inflammation and thrombophilia?
作者信息
Maier Cheryl L, Truong Alexander D, Auld Sara C, Polly Derek M, Tanksley Christin-Lauren, Duncan Alexander
机构信息
Department of Pathology and Laboratory Medicine, Center for Transfusion and Cellular Therapies, Emory University School of Medicine, Atlanta, GA30322, USA.
Emory Critical Care Center, Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, Department of Medicine, Emory University School of Medicine, Atlanta, GA30322, USA.
出版信息
Lancet. 2020 Jun 6;395(10239):1758-1759. doi: 10.1016/S0140-6736(20)31209-5. Epub 2020 May 25.
Abstract
摘要
相似文献
1
COVID-19-associated hyperviscosity: a link between inflammation and thrombophilia?新冠病毒感染相关的高黏滞血症：炎症与血栓形成倾向之间的联系？
Lancet. 2020 Jun 6;395(10239):1758-1759. doi: 10.1016/S0140-6736(20)31209-5. Epub 2020 May 25.
2
Research in brief: Coagulopathy in COVID-19: Determining and managing thrombotic risk in COVID-19 infection.简要研究：新型冠状病毒肺炎中的凝血功能障碍：确定和管理新型冠状病毒肺炎感染中的血栓形成风险
Clin Med (Lond). 2020 Jul;20(4):e59. doi: 10.7861/clinmed.rib.20.4.2.
3
Severe COVID-19 disease and thromboinflammation.重症新型冠状病毒肺炎与血栓性炎症
Arch Cardiol Mex. 2020;90(3):257-258. doi: 10.24875/ACM.M20000075.
4
Coronavirus Disease 2019, Prothrombotic Factors, and Venous Thromboembolism.2019冠状病毒病、血栓形成前因素与静脉血栓栓塞症
Semin Thromb Hemost. 2020 Oct;46(7):772-776. doi: 10.1055/s-0040-1710337. Epub 2020 May 11.
5
Management of venous thromboembolism during the COVID-19 pandemic.2019冠状病毒病大流行期间静脉血栓栓塞的管理
J Vasc Surg Venous Lymphat Disord. 2020 Sep;8(5):897-898. doi: 10.1016/j.jvsv.2020.05.005. Epub 2020 May 23.
6
Venous thromboembolism in non-critically ill patients with COVID-19 infection.COVID-19 感染非危重症患者的静脉血栓栓塞症。
Thromb Res. 2020 Sep;193:166-169. doi: 10.1016/j.thromres.2020.07.033. Epub 2020 Jul 17.
7
Hypercoagulability and coronavirus disease 2019-associated hypoxemic respiratory failure: Mechanisms and emerging management paradigms.高凝状态与2019冠状病毒病相关的低氧性呼吸衰竭：机制与新出现的管理模式
J Trauma Acute Care Surg. 2020 Dec;89(6):e177-e181. doi: 10.1097/TA.0000000000002938.
8
Prevalence of venous thromboembolism in critically ill patients with COVID-19.新型冠状病毒肺炎危重症患者静脉血栓栓塞症的患病率
Br J Haematol. 2020 Aug;190(3):e134-e137. doi: 10.1111/bjh.16908. Epub 2020 Jun 24.
9
Attention should be paid to venous thromboembolism prophylaxis in the management of COVID-19.在新型冠状病毒肺炎（COVID-19）的治疗中应注意静脉血栓栓塞的预防。
Lancet Haematol. 2020 May;7(5):e362-e363. doi: 10.1016/S2352-3026(20)30109-5. Epub 2020 Apr 9.
10
Venous thromboembolism and COVID-19.静脉血栓栓塞与2019冠状病毒病
Respir Med Res. 2020 Nov;78:100759. doi: 10.1016/j.resmer.2020.100759. Epub 2020 Apr 28.
引用本文的文献
1
Anticoagulant use before COVID-19 diagnosis prevent COVID-19 associated acute venous thromboembolism or not: A systematic review and meta-analysis.新冠病毒病诊断前使用抗凝剂能否预防新冠病毒病相关急性静脉血栓栓塞：一项系统评价与荟萃分析
World J Methodol. 2024 Sep 20;14(3):92983. doi: 10.5662/wjm.v14.i3.92983.
2
Diagnostic potential of blood plasma longitudinal viscosity measured using Brillouin light scattering.利用布里渊光散射测量血浆纵向粘度的诊断潜力。
Proc Natl Acad Sci U S A. 2024 Aug 13;121(33):e2323016121. doi: 10.1073/pnas.2323016121. Epub 2024 Aug 1.
3
Associations between prior COVID-19 infection and venous thromboembolism following common plastic surgery operations.既往 COVID-19 感染与常见整形手术后静脉血栓栓塞的相关性。
J Plast Reconstr Aesthet Surg. 2024 Jul;94:198-209. doi: 10.1016/j.bjps.2024.04.013. Epub 2024 Apr 20.
4
The interplay between inflammation and thrombosis in COVID-19: Mechanisms, therapeutic strategies, and challenges.2019冠状病毒病中炎症与血栓形成的相互作用：机制、治疗策略及挑战
Thromb Update. 2022 Aug;8:100117. doi: 10.1016/j.tru.2022.100117. Epub 2022 Jul 9.
5
Mortality, critical illness, and mechanical ventilation among hospitalized patients with COVID-19 on therapeutic anticoagulants.接受治疗性抗凝治疗的COVID-19住院患者的死亡率、重症疾病及机械通气情况。
Thromb Update. 2021;2:100027. doi: 10.1016/j.tru.2020.100027. Epub 2021 Mar 19.
6
Gastric Ischemia after SARS-CoV-2 Infection.新型冠状病毒感染后的胃缺血
Life (Basel). 2023 Dec 27;14(1):47. doi: 10.3390/life14010047.
7
Ultrasound-assisted catheter-directed thrombolysis in a patient with COVID-19 infection and bilateral intermediate-to-high-risk pulmonary embolism: a case report.超声辅助导管定向溶栓治疗 COVID-19 感染合并双侧中高危肺栓塞患者：一例报告
Eur Heart J Case Rep. 2024 Jan 8;8(1):ytad628. doi: 10.1093/ehjcr/ytad628. eCollection 2024 Jan.
8
Sialylated Glycan Bindings from SARS-CoV-2 Spike Protein to Blood and Endothelial Cells Govern the Severe Morbidities of COVID-19.SARS-CoV-2 刺突蛋白与血液和血管内皮细胞的唾液酸化聚糖结合决定了 COVID-19 的严重发病机制。
Int J Mol Sci. 2023 Dec 1;24(23):17039. doi: 10.3390/ijms242317039.
9
Coronavirus disease 2019-associated thrombotic microangiopathy treated with plasma exchange and antihypertensive therapy in a patient with HIV: A case report with literature review.HIV 感染者新冠病毒病相关血栓性微血管病经血浆置换和降压治疗：病例报告并文献复习。
Medicine (Baltimore). 2023 Oct 13;102(41):e35469. doi: 10.1097/MD.0000000000035469.
10
Predictive value of hematological indices on incidence and severity of pulmonary embolism in COVID-19 patients.血细胞指标对 COVID-19 患者肺栓塞发生率和严重程度的预测价值。
Immun Inflamm Dis. 2023 Sep;11(9):e1012. doi: 10.1002/iid3.1012.
本文引用的文献
1
Autopsy Findings and Venous Thromboembolism in Patients With COVID-19.新型冠状病毒肺炎患者的尸检结果与静脉血栓栓塞
Ann Intern Med. 2020 Dec 15;173(12):1030. doi: 10.7326/L20-1206.
2
The procoagulant pattern of patients with COVID-19 acute respiratory distress syndrome.COVID-19 急性呼吸窘迫综合征患者的促凝模式。
J Thromb Haemost. 2020 Jul;18(7):1747-1751. doi: 10.1111/jth.14854. Epub 2020 May 6.
3
Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy.抗凝治疗与伴有凝血功能障碍的严重 2019 冠状病毒病患者的死亡率降低相关。
J Thromb Haemost. 2020 May;18(5):1094-1099. doi: 10.1111/jth.14817. Epub 2020 Apr 27.
4
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice - Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue.临床实践中治疗性血液成分单采术的使用指南——美国血液成分单采学会写作委员会基于证据的方法：第八期特刊
J Clin Apher. 2019 Jun;34(3):171-354. doi: 10.1002/jca.21705.
5
Hyperviscosity syndrome.高黏滞综合征
J Intensive Care Med. 1995 May-Jun;10(3):128-41. doi: 10.1177/088506669501000304.
Zotero 插件